Literature DB >> 24614420

Venous thoracic outlet syndrome: approach to diagnosis and treatment with focus on affected athletes.

Ted A Farrar1, George Rankin, Matthew Chatfield.   

Abstract

Venous thoracic outlet syndrome is a relatively rare condition. One variety that is related to effort, often referred to as Paget-Schroetter syndrome, is seen more often in persons who are athletic or occupationally active. This condition can have significant morbidity if left untreated. Diagnosis is best undertaken with duplex ultrasound or venogram. The current standard for treatment includes catheter-directed thrombolysis with surgical correction of the thoracic outlet and subclavian vein with some variability of this depending upon the presentation. Some cases may require anticoagulation for approximately 12 wk. Return to play should be expected in successfully corrected cases that include a collaborative rehabilitation program.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24614420     DOI: 10.1249/JSR.0000000000000035

Source DB:  PubMed          Journal:  Curr Sports Med Rep        ISSN: 1537-890X            Impact factor:   1.733


  4 in total

Review 1.  Paget-Schroetter syndrome: treatment of venous thrombosis and outcomes.

Authors:  Patrick Hangge; Lisa Rotellini-Coltvet; Amy R Deipolyi; Hassan Albadawi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

2.  SCREENING FOR REFERRAL BY A SPORTS PHYSICAL THERAPIST REVEALS AN EFFORT THROMBOSIS IN A COLLEGIATE PITCHER: A CASE REPORT.

Authors:  William R VanWye; Jase Pinerola; Karen Craig Ogle; Harvey W Wallmann
Journal:  Int J Sports Phys Ther       Date:  2016-08

3.  Sport and Venous Thromboembolism—Site, Accompanying Features, Symptoms, and Diagnosis.

Authors:  Thomas Hilberg; Pia Ransmann; Thorsten Hagedorn
Journal:  Dtsch Arztebl Int       Date:  2021-03-19       Impact factor: 5.594

4.  Thoracic Outlet Syndrome in Sport: A Systematic Review.

Authors:  Thomas Garraud; Germain Pomares; Pauline Daley; Pierre Menu; Marc Dauty; Alban Fouasson-Chailloux
Journal:  Front Physiol       Date:  2022-06-08       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.